Hajeer A H, Bernstein R M
Department of Rheumatology, University of Manchester Medical School, UK.
Clin Exp Immunol. 1993 Dec;94(3):544-7. doi: 10.1111/j.1365-2249.1993.tb08232.x.
Inhibition ELISA and immunoblotting were used to examine the antigenic cross-reactivity claimed to exist between mycobacterial 65-kD heat shock protein (hsp65) and human lactoferrin. Commercially available anti-lactoferrin antibodies produced using either Freund's complete (FCA) or Freund's incomplete adjuvant were tested for binding to recombinant mycobacterial hsp65. Both antibody preparations showed reactivity with hsp65, this being greater with the antibody produced using FCA. However, we found no evidence of a cross-reaction. Lactoferrin failed to inhibit anti-hsp65 reactivity, while hsp65 itself did. Affinity purified anti-lactoferrin antibody showed no reaction with hsp65 by ELISA or immunoblotting. These data suggest that commercial anti-lactoferrin preparations are contaminated with antibodies to hsp65. A commercial anti-albumin antibody also bound to hsp65 in ELISA, so this may be a more general phenomenon.
采用抑制性酶联免疫吸附测定法(ELISA)和免疫印迹法,检测了分枝杆菌65-kD热休克蛋白(hsp65)与人乳铁蛋白之间声称存在的抗原交叉反应性。使用弗氏完全佐剂(FCA)或弗氏不完全佐剂制备的市售抗乳铁蛋白抗体,检测其与重组分枝杆菌hsp65的结合情况。两种抗体制剂均显示出与hsp65的反应性,其中使用FCA制备的抗体反应性更强。然而,我们未发现交叉反应的证据。乳铁蛋白未能抑制抗hsp65反应性,而hsp65自身却能抑制。经亲和纯化的抗乳铁蛋白抗体通过ELISA或免疫印迹法检测,未显示与hsp65有反应。这些数据表明,市售抗乳铁蛋白制剂被抗hsp65抗体污染。一种市售抗白蛋白抗体在ELISA中也与hsp65结合,所以这可能是一种更普遍的现象。